MCs activated CAFs and TGF-β signal pathway to increase the resistance to Gemcitabine/Nabpaclitaxel and promote tumor invasion in pancreatic cancer via PAR-2, ERK1/2 and Akt activation (84). The gene discussed is AKT1; the disease is familial pancreatic carcinoma.